TechFlex is dedicated to assisting startups in the Series A and Seed money stages to achieve their objectives through a structured and supportive framework. Our approach focuses on providing tailored solutions that address the unique challenges faced by early-stage companies.
TechFlex is the catalyst for success in the medical device industry, offering comprehensive support to growing companies. With expertise spanning from initial concept to market entry, TechFlex provides tailored solutions, cutting-edge technologies, and regulatory guidance.
The new FDA 510(k) clearances for RapidAI include Rapid LMVO, which facilitates assessment of ischemic stroke, and Rapid MLS, which aids in the quantification of midline shifts with potential brain injuries.
Read the full article at: www.diagnosticimaging.com
